Accretion Nutraveda SME IPO Details

Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.

The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.

Accretion Nutraveda was established with a vision to promote health and wellness through nutraceutical and herbal products, combining traditional knowledge with modern science. The company has gradually built its presence in the wellness industry by focusing on quality formulations and customer-centric offerings. Backed by experienced promoters with knowledge in healthcare and nutrition, Accretion Nutraveda has positioned itself as a growing player in the preventive healthcare space.

The company is engaged in the development, manufacturing, and marketing of a wide range of nutraceutical products, including dietary supplements, herbal extracts, and wellness solutions. Its business model revolves around product innovation, contract manufacturing, and distribution through multiple channels such as online platforms and retail networks. With increasing awareness towards healthy living, the company aims to expand its footprint across domestic and select international markets.